指南与共识细菌感染、耐药与抗菌药物

IDSA 2025年复杂性尿路感染抗菌疗程指南

Clinical Practice Guidelines by Infectious Diseases Society of America (IDSA): 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections--Duration of Antibiotics for Complicated UTI.
指南 / 共识 · Clin Infect Dis · 2026-01-01

IDSA基于系统综述与GRADE方法制定2025年复杂性尿路感染(cUTI)抗菌疗程指南。对于治疗有效的cUTI患者,无论是否合并革兰阴性菌血症,建议短疗程(氟喹诺酮类5-7天或非氟喹诺酮类7天)而非长疗程。但疑似急性细菌性前列腺炎的男性发热性UTI患者可能受益于10-14天长疗程。

要点

  • cUTI治疗有效者可用短疗程:氟喹诺酮类5-7天或非氟喹诺酮类7天。
  • 合并革兰阴性菌血症不影响短疗程的适用性。
  • 疑似急性细菌性前列腺炎的男性发热性UTI建议10-14天。

核心结论

  • cUTI短疗程抗菌治疗与长疗程疗效相似,但疑似急性细菌性前列腺炎的男性发热性UTI除外。

研究设计与样本

  • 基于2000年以来发表文献的系统综述,比较短疗程(5-7天)与长疗程(10-14天)的获益与危害。
  • 采用GRADE方法评估证据质量和推荐强度。

主要发现

  • 治疗有效的cUTI患者,无论是否合并革兰阴性菌血症,短疗程与长疗程疗效相似。
  • 疑似急性细菌性前列腺炎的男性发热性UTI可能从10-14天长疗程中获益。
  • 口服β-内酰胺类短疗程可能需要更高剂量才能达到疗效。

关键数值与推荐

  • 氟喹诺酮类短疗程为5-7天,非氟喹诺酮类短疗程为7天。
  • 疑似急性细菌性前列腺炎的男性发热性UTI长疗程为10-14天。
  • 有效抗菌药物需在尿液和相关组织中达到治疗浓度并对致病菌有活性。

临床怎么用

  • 对治疗有效的cUTI患者优先选择短疗程以促进抗菌药物管理。
  • 男性发热性UTI疑似急性细菌性前列腺炎时应延长至10-14天。
  • 使用口服β-内酰胺类短疗程时需考虑提高剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: These recommendations provide guidance on the optimal duration of antibiotics in patients with complicated urinary tract infection (cUTI), especially in presence of associated Gram-negative bacteremia. METHODS: The panel's recommendations are based upon evidence derived from systematic literature reviews which focused on comparative benefits and harms of shorter (5-7 days) vs prolonged (10-14 days) duration of antibiotics, including publications since 2000. These recommendations adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. RESULTS: The guidelines panel suggests that patients with cUTI who are improving on effective therapy can be treated with shorter duration of antimicrobials (either 5-7 days of a fluoroquinolone or 7 days of a non-fluoroquinolone) rather than longer courses of antibiotics, regardless of the presence of associated Gram-negative bacteremia. An effective antimicrobial agent achieves therapeutic levels in the urine and relevant tissue and is active against the causative pathogen. However, men with febrile UTI in whom acute bacterial prostatitis is suspected may benefit from a longer treatment duration (10-14 days), and a short courses of oral beta lactams may require higher doses for efficacy. CONCLUSIONS: Shorter durations of antibiotics for cUTI provide similar efficacy as longer courses, except in men with febrile UTI in whom acute bacterial prostatitis is suspected. This recommendation places a high value on antibiotic stewardship considerations as well as reducing the burden of antimicrobial administration from a healthcare perspective and reducing the burden of taking antibiotics from a patient perspective.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Trautner BW, Cortés-Penfield NW, Gupta K, et al. Clinical Practice Guidelines by Infectious Diseases Society of America (IDSA): 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections--Duration of Antibiotics for Complicated UTI. Clin Infect Dis. 2026. PMID: 41419448. doi:10.1093/cid/ciaf462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。